TAP-Block in Abdominal Aortic Surgery (TAP-CACAO)

University Hospital Center (CHU) Dijon Bourgogne

Status and phase: Completed; Phase 4

Conditions: Aortic Aneurysm, Abdominal

Treatments: Drug: Ropivacaine; Drug: Placebo

Study type: Interventional

Funder types: Other

Identifiers

NCT03657979

2011-002355-34

Details and patient eligibility

About

The primary outcome of this study was the evaluation of the efficacy of TAP block on pain intensity following open abdominal aortic surgery.

Enrollment: 50 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Open abdominal aortic surgery (aneurysm or aortobifemoral bypass)
• Person who has given his written consent

Exclusion criteria

• Emergency surgery
• Patient with infection
• Use of opioids in the long term
• History of chronic pain
• Higher functions incompatible with the functioning of the PCA
• Patients under guardianship

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Quadruple Blind

---

50 participants in 2 patient groups, including a placebo group

Ropivacaine

Experimental group

Description:

Conventional PCA morphine +TAP-block ropivacaine 0.2%

Treatment:

Drug: Ropivacaine

TAP-block with placebo

Placebo Comparator group

Description:

Conventional PCA morphine treatment with TAP-block with placebo

Treatment:

Drug: Placebo